Silvia Racca Selected Research

Silvia Racca Research Topics

4	Neoplasms (Cancer) 06/2022 - 05/2006
2	Carcinogenesis 09/2008 - 05/2006
1	Drug-Related Side Effects and Adverse Reactions 06/2022
1	Alopecia (Baldness) 06/2022
1	Heartburn (Pyrosis) 06/2022
1	Asthenia 06/2022
1	Mucositis 06/2022
1	Dysgeusia (Parageusia) 06/2022
1	Constipation 06/2022
1	Pain (Aches) 06/2022
1	Nausea 06/2022
1	Colorectal Neoplasms (Colorectal Cancer) 06/2022
1	Pancreatic Neoplasms (Pancreatic Cancer) 04/2022
1	Inflammation (Inflammations) 01/2014
1	Prostatic Neoplasms (Prostate Cancer) 08/2009
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 06/2009
1	Breast Neoplasms (Breast Cancer) 05/2006

2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 09/2008 - 05/2006
1	Biological ProductsIBA 06/2022
1	BromidesIBA 12/2014
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2014
1	Hormones (Hormone)IBA 08/2009
1	Interleukin-6 (Interleukin 6)IBA 08/2009
1	Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA 08/2009
1	11-beta-Hydroxysteroid Dehydrogenases (11beta Hydroxysteroid Dehydrogenase)IBA 08/2009
1	GlucocorticoidsIBA 08/2009
1	AndrogensIBA 08/2009
1	nilotinib FDA Link 06/2009
1	Imatinib Mesylate (Gleevec)FDA Link 06/2009
1	Dasatinib (BMS 354825)FDA Link 06/2009
1	Tyrosine Kinase InhibitorsIBA 06/2009
1	EnzymesIBA 09/2008
1	AntioxidantsIBA 09/2008
1	9,10-Dimethyl-1,2-benzanthraceneIBA 09/2008
1	beta-NaphthoflavoneIBA 05/2006
1	Protective AgentsIBA 05/2006
1	Pharmaceutical PreparationsIBA 05/2006
1	anthraceneIBA 05/2006
1	7,12-dimethylbenz(a)anthracene-DNA adduct (DMBA-DNA adduct)IBA 05/2006
1	SalicylatesIBA 05/2006
1	DNA AdductsIBA 05/2006

2	Drug Therapy (Chemotherapy) 06/2022 - 04/2022